InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: jessellivermore post# 18416

Sunday, 10/20/2013 7:19:51 PM

Sunday, October 20, 2013 7:19:51 PM

Post# of 425939
I agree, but top of this the managment has to clarify the exact situation (pls not comment the management).

We have to know more about the exact situation ie.: did they received anything? Will they contact w FDA reg AdCom / science change?, etc.

(Maybe) we will receive some answer during the Q3 CC.

The current picture is not so bright (AdCom vote and FDA BD), however we still have a binding SPA and Vascepa is safe and effective reg TG lowering.

ps.: the current atitude of FDA is definitely inceasing CVE events, so they have to approve ANCHOR :)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News